Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Assessment of Utero-ovarian Transposition (UOT) for Fertility Preservation in Patients With Pelvic Malignancies Undergoing Whole Pelvic Radiotherapy (WPXRT)

NCT07419490 is registered in ClinicalTrials.gov with University of South Florida as lead sponsor.

NCT NCT07419490
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07419490 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Assessment of Utero-ovarian Transposition (UOT) for Fertility Preservation in Patients With Pelvic Malignancies Undergoing Whole Pelvic Radiotherapy (WPXRT)
Lead sponsor
University of South Florida
Phase
Not applicable
Overall status
Recruiting
Start date
April 1, 2026
Completion date
June 30, 2031
Enrollment
26 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal (colon or rectal) cancer, oncofertility, pelvic malignancies